Lexicon Pharmaceuticals
LXRX
#6705
Rank
$0.79 B
Marketcap
$1.78
Share price
10.56%
Change (1 day)
25.35%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2023 (TTM): -$0.68

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$0.15. In 2022 the company made an earnings per share (EPS) of -$0.61 an increase over its 2021 EPS that were of -$0.61.

EPS history for Lexicon Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.6811.48%
2022-$0.61-0%
2021-$0.6110.91%
2020-$0.55-145.08%
2019$1.22-206.09%
2018-$1.15-5.74%
2017-$1.22-10.95%
2016-$1.372640%
2015-$0.05000-96.34%
2014-$1.36-2.53%
2013-$1.40-9.09%
2012-$1.54-37.14%
2011-$2.450%
2010-$2.45-39.66%
2009-$4.063.57%
2008-$3.92-8.2%
2007-$4.27-24.69%
2006-$5.6742.11%
2005-$3.99-22.97%
2004-$5.18-35.09%
2003-$7.98-0%
2002-$7.9862.86%
2001-$4.90-19.54%
2000-$6.09

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
$18.99-12,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$5.89-4,026.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
$41.91-28,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-$5.84 3,793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$10.01-6,773.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-$0.02000-86.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-$0.75 400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$0.38-353.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-$29.29 19,426.67%๐Ÿ‡บ๐Ÿ‡ธ USA